Anti-C5 (Eculizumab)

Anti-C5 [Eculizumab], Recombinant, IgG1 kappa, Human
Artikelnummer
ABAAb00296-10.0-BT
Verpackungseinheit
1 mg
Hersteller
Absolute Antibody

Verfügbarkeit: wird geladen...
Preis wird geladen...
CloneID: Eculizumab

Antigen Long Description: C5 is activated by C5 converatse into C5a, an anaphylatoxin, and C5b a component of the membrane attack complex.

Buffer Composition: PBS only.

Uniprot Accession No.: P01031

Specificity Statement: Binds human C5 centred in the MG7 domain, at an epitope spanning Lys-879 to Arg-885 (Jore et al. 2016) Polymorphisms at Arg-885 correlate with drug resistance. Eculizumab demonstrates no appreciable species cross-reactivity. It is highly species specific. with no appreciable activity against chimpanzee, baboon, rhesus or cynomologous monkey, pig, rabbit, guinea pig, or rat complement

Application Notes (Clone): This antibody inhibits activation of C5. The human Fab version (Ab00296-10.6) of this antibody was used by Jore et al. (2016, PMID: 27018802) to determine the binding site of this antibody to C5.
Mehr Informationen
Artikelnummer ABAAb00296-10.0-BT
Hersteller Absolute Antibody
Hersteller Artikelnummer Ab00296-10.0-BT
Verpackungseinheit 1 mg
Mengeneinheit STK
Reaktivität Human
Klonalität Recombinant
Methode ELISA
Isotyp IgG1 kappa
Wirt Human
Produktinformation (PDF) Download
MSDS (PDF) Download